Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T) - Hambrock, A; de Oliveira Franz, C B; Hiller, S (J Pharmacol Exp Ther, 2006)
et al.